Thirteen projects awarded under the 2025 round of the Efficiency Research program

The Efficiency Research program of the Dutch Organization for Health Research and Development (ZonMw) is intended to develop socially relevant and high-quality knowledge about the effectiveness and costs of innovative and existing non-pharmaceutical diagnostic and therapeutic interventions within the basic insurance package or long-term care. 

The following types of projects are eligible for the Efficiency Research program:

• The project provides knowledge about the effectiveness and costs of non-pharmacotherapeutic interventions;
• The project is a comparison of intervention with standard care;
• The project concerns comparative research into interventions with proven safety and plausible efficacy.

In July 2024, 13 projects were awarded subsidies from the 2025 open round of the Efficiency Research program, including one project on e-health, one project on extracorporeal treatments, one project in orthopedics, one project in neurology, one project in urology, two projects in obstetrics and gynecology, one project in radiotherapy and one project in the cardiovascular area. 

Examples of the awarded projects include:

• Omitting re-excision in thin melanoma;
• Direct discharge of syncope patients from the emergency department;
• Restraint with blood transfusions in patients treated with a heart-lung machine;
• Effectiveness of a menstrual health app for adolescents with menstrual symptoms;
• Effectiveness of a blood test and self-monitoring for predicting pre-eclampsia and related complications.

The subsidy within this round is intended to research which treatment method gives the best results and at what cost. The projects will start by the end of 2024 at the latest.

See more information in Dutch here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.